Bart Bacak, PhD, MD

Scientific Co-Founder Drexel Univ. and Univ. of Rochester

World-leading expert on the Hiccups and physician at University of Rochester (NY).  Bart’s work has advanced the understanding of Hiccups science, and this mechanism of action is the subject of scientific research to be submitted for publication this year.

MJ Kievman, Founder

Colby College

Patient-founder of Meter Health, MJ developed version 1.0 of Meter’s technology and was granted her first patent at age 15. MJ’s story captivated the global media, and began to build awareness for clinically-significant hiccups and the need for a new treatment.

Dave Wilson, Chief Strategy Officer

Genzyme, Quintiles, PPD

Bringing 30+ years in biopharma, CROs, and medical devices overseeing programs to support value messages across stakeholder groups for rare disease therapeutics, Dave’s experience includes leadership roles at Genzyme, Quintiles, and PPD.

Andrew Robinson, RPh, COO

CVS, SpecialtyScripts

Pharmacist by training, Andrew left CVS in 2003 to start SpecialtyScripts, a specialty pharmacy. Andrew grew the company from 3 employees in MA to a national footprint with $250 million in annual sales, exiting to Cardinal Health and Walgreens.

Adam Kievman, CEO

Alexion, Alnylam, Moderna

With 25 years’ experience building leadership teams and scaling top biopharma and VC-backed biotech companies, Adam’s executive-level experience includes Alexion, Moderna, and Alnylam.